ATE545655T1 - Fgfr-bindende peptide - Google Patents
Fgfr-bindende peptideInfo
- Publication number
- ATE545655T1 ATE545655T1 AT05748535T AT05748535T ATE545655T1 AT E545655 T1 ATE545655 T1 AT E545655T1 AT 05748535 T AT05748535 T AT 05748535T AT 05748535 T AT05748535 T AT 05748535T AT E545655 T1 ATE545655 T1 AT E545655T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- fgfr
- ncam
- peptide sequences
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Psychology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400963 | 2004-06-18 | ||
PCT/DK2005/000400 WO2005123759A2 (en) | 2004-06-18 | 2005-06-17 | Fgfr binding peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE545655T1 true ATE545655T1 (de) | 2012-03-15 |
Family
ID=35510321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05748535T ATE545655T1 (de) | 2004-06-18 | 2005-06-17 | Fgfr-bindende peptide |
Country Status (11)
Country | Link |
---|---|
US (1) | US20090074774A1 (pt-PT) |
EP (1) | EP1765861B1 (pt-PT) |
JP (1) | JP2008504236A (pt-PT) |
CN (1) | CN101027320A (pt-PT) |
AT (1) | ATE545655T1 (pt-PT) |
AU (1) | AU2005254613A1 (pt-PT) |
BR (1) | BRPI0512254A (pt-PT) |
CA (1) | CA2570267A1 (pt-PT) |
MX (1) | MXPA06014804A (pt-PT) |
WO (1) | WO2005123759A2 (pt-PT) |
ZA (1) | ZA200610546B (pt-PT) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1886422A (zh) * | 2003-09-30 | 2006-12-27 | 恩卡姆医药公司 | 调节细胞存活、分化和/或突触可塑性的方法 |
EP2412727B1 (en) | 2006-02-14 | 2016-06-29 | University Of Tasmania Through The Menzies Research Institute | Metallothionein-derived peptide fragments |
WO2007110079A2 (en) * | 2006-03-29 | 2007-10-04 | Enkam Pharmaceuticals A/S | Targeted delivery of fgfr ligands into the brain |
CN101619093B (zh) * | 2009-05-26 | 2011-12-07 | 中国人民解放军第三军医大学野战外科研究所 | 具有促进成纤维细胞生长因子受体3活性的多肽及其筛选方法和应用 |
EP2483407A2 (en) | 2009-09-30 | 2012-08-08 | President and Fellows of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
ES2673872T3 (es) | 2012-06-05 | 2018-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Mimético del péptido NCAM para su uso en el tratamiento de trastorno de depresión mayor |
CN109867724B (zh) * | 2019-04-19 | 2020-09-15 | 温州医科大学 | 一种fgfr抗体及其在脊髓损伤治疗中的用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036945A (en) * | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4599311A (en) * | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5693488A (en) * | 1994-05-12 | 1997-12-02 | The Rockefeller University | Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and methods of use thereof |
US20020104122A1 (en) * | 1994-06-17 | 2002-08-01 | Kirin Beer Kabushiki Kaisha | Methods for producing a plant with enhanced resistance to pathogenic fungi |
EP2275551B1 (en) * | 1999-10-29 | 2015-04-08 | Novartis Vaccines and Diagnostics S.r.l. | Neisserial antigenic peptides |
GB0014870D0 (en) * | 2000-06-16 | 2000-08-09 | King S College London | Peptides |
CA2457164A1 (en) * | 2001-08-17 | 2003-02-27 | Enkam Pharmaceuticals A/S | Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
WO2005049641A2 (en) * | 2003-11-21 | 2005-06-02 | Ace Biosciences A/S | Surface-located campylobacter jejuni polypeptides |
-
2005
- 2005-06-17 CN CNA2005800284125A patent/CN101027320A/zh active Pending
- 2005-06-17 AU AU2005254613A patent/AU2005254613A1/en not_active Abandoned
- 2005-06-17 AT AT05748535T patent/ATE545655T1/de active
- 2005-06-17 WO PCT/DK2005/000400 patent/WO2005123759A2/en active Application Filing
- 2005-06-17 EP EP05748535A patent/EP1765861B1/en active Active
- 2005-06-17 CA CA002570267A patent/CA2570267A1/en not_active Abandoned
- 2005-06-17 US US11/629,896 patent/US20090074774A1/en not_active Abandoned
- 2005-06-17 MX MXPA06014804A patent/MXPA06014804A/es not_active Application Discontinuation
- 2005-06-17 BR BRPI0512254-6A patent/BRPI0512254A/pt not_active Application Discontinuation
- 2005-06-17 JP JP2007515781A patent/JP2008504236A/ja active Pending
-
2006
- 2006-12-15 ZA ZA200610546A patent/ZA200610546B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101027320A (zh) | 2007-08-29 |
JP2008504236A (ja) | 2008-02-14 |
EP1765861B1 (en) | 2012-02-15 |
CA2570267A1 (en) | 2005-12-29 |
BRPI0512254A (pt) | 2008-02-19 |
EP1765861A2 (en) | 2007-03-28 |
WO2005123759A2 (en) | 2005-12-29 |
WO2005123759A3 (en) | 2006-05-04 |
MXPA06014804A (es) | 2007-03-23 |
ZA200610546B (en) | 2008-06-25 |
AU2005254613A1 (en) | 2005-12-29 |
WO2005123759A8 (en) | 2006-03-09 |
US20090074774A1 (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200610546B (en) | FGFR binding peptides | |
WO2007051477A8 (en) | Neurotrophin-derived peptide sequences | |
EP2385061A3 (en) | Neuritogenic peptides | |
WO2006125227A3 (en) | Fibroblast activation protein inhibitor compounds and methods | |
WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
WO2007093177A3 (en) | Metallothionein-derived peptide fragments | |
ATE469921T1 (de) | Lpa-haltige verbindungen | |
WO2007146085A3 (en) | Creatine phosphate prodrugs, compositions and uses thereof | |
NO20052222L (no) | Farmasoytisk preparat omfattende krystallinsk sibutraminmetansulfonathemihydrat | |
ATE458746T1 (de) | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs | |
WO2007074456A3 (en) | Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids | |
WO2000018801A3 (en) | Ncam binding compounds | |
WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
DK1373502T3 (da) | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf | |
ATE552273T1 (de) | Verbindungen, die die differenzierung, proliferation, regeneration, plastizität und das überleben von zellen beeinflussen können | |
WO2005118920A3 (en) | Methods for generating neuronal cells from human embryonic stem cells and uses thereof | |
JP2008508363A5 (pt-PT) | ||
WO2009068042A3 (en) | Novel peptides derived from ncam (fgls) | |
WO2007071248A3 (en) | Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins | |
WO2007045243A3 (en) | Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 | |
WO2005025514A3 (en) | Compounds that modulate neuronal growth and their uses | |
IL176898A0 (en) | Growth factor-binding compounds and methods of use | |
WO2005121168A3 (en) | Heparin binding peptide | |
DE602006017806D1 (de) | Behandlung von neurodegeneration | |
Janke et al. | The arginine mimicking β-amino acid β3hPhe (3-H2N-CH2) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors |